Stock analysts at Needham & Company lifted their price target on shares of Gilead Sciences (NASDAQ:GILD) from $85.00 to $95.00 in a report issued on Wednesday, AnalystRatings.Net reports. The firm currently has a “buy” rating on the stock. Needham & Company’s target price points to a potential upside of 15.83% from the company’s current price. Gilead Sciences, Inc. (NASDAQ:GILD) stock opened at $82.70 in last trading session, and closed at $82.81, trading in the range of $81.88 – $83.20. The stock showed a positive weekly performance of 0.99%.
Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, announced that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, is scheduled to speak at the Citi 2014 Healthcare Conference in New York City on February 24, 2014 at 8:50 a.m. EST. Merck & Co., Inc. (NYSE:MRK) shares closed at $55.81 on last trade day, by gaining 1.40%. Stock 52 week range is $42.10 – $56.00. Company’s market capitalization is $163.33 billion.
Eli Lilly & Co. (NYSE:LLY) shares were up 5.14% after the company announced encouraging data from a phase III study on its oncology candidate, ramucirumab. The worldwide, randomized, double-blind REVEL study compared the use of ramucirumab in combination with Sanofi’s Taxotere (docetaxel) to Taxotere plus placebo in second-line non-small cell lung cancer (:NSCLC) patients. Eli Lilly & Co. (NYSE:LLY) stock decreased -0.07% and finished the last session at $58.05. The EPS of the stock remained 4.31. Company’s market capitalization is $65.40 billion.
Shares of Mylan (NASDAQ:MYL) saw a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 26,589,601 shares, a decline of 6.3% from the January 15th total of 28,386,223 shares, American Banking and Market News reports. Based on an average daily volume of 3,100,887 shares, the short-interest ratio is presently 8.6 days. Currently, 7.0% of the shares of the company are sold short. Mylan Inc (NASDAQ:MYL) stock opened at $50.98 in last trading session and closed at $52.26. The 52 week range of the stock is $27.66 – $52.44 and the day range was $50.55 – $52.44.
Leave a Reply